Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

GeneScience's GenSci155 Wins NMPA Clinical Trial Approval – Long‑Acting IGF‑1 Analog Targets Bronchopulmonary Dysplasia and Rare Growth Disorder
CompanyDrug

GeneScience’s GenSci155 Wins NMPA Clinical Trial Approval – Long‑Acting IGF‑1 Analog Targets Bronchopulmonary Dysplasia and Rare Growth Disorder

Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced that its subsidiary, GeneScience Pharmaceuticals Co., Ltd., has received clinical trial approval from China's National Medical Products Administration (NMPA)…

Asieris Pharmaceuticals Inks Exclusive CEVIRA® License with Theramex – First‑in‑Class Cervical Photodynamic Therapy Enters European Commercialization

Asieris Pharmaceuticals Inks Exclusive CEVIRA® License with Theramex – First‑in‑Class Cervical Photodynamic Therapy Enters European Commercialization

Betta Pharmaceuticals Secures FDA IND Approval for BPI‑572270 Capsules – Novel Pan‑RAS "Non‑Degradative Molecular Glue" Inhibitor Advances into U.S. Clinical Trials

Betta Pharmaceuticals Secures FDA IND Approval for BPI‑572270 Capsules – Novel Pan‑RAS “Non‑Degradative Molecular Glue” Inhibitor Advances into U.S. Clinical Trials

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
China Resources Double-Crane Gets NMPA Approval for Semaglutide Biosimilar Clinical Trial
CompanyDrug

China Resources Double-Crane Gets NMPA Approval for Semaglutide Biosimilar Clinical Trial

First Patient Dosed in Abbisko's Phase II Trial of ABSK061 and ABSK043 in FGFR2/3 Altered Tumors
CompanyDrug

First Patient Dosed in Abbisko’s Phase II Trial of ABSK061 and ABSK043 in FGFR2/3 Altered Tumors

Jiangsu Hengrui Receives NMPA Approval for HRS-6208 Solid Tumor Clinical Study
CompanyDrug

Jiangsu Hengrui Receives NMPA Approval for HRS-6208 Solid Tumor Clinical Study

Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
CompanyDrug

Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency

Epigenic Therapeutics Receives Approval for EPI-003 Clinical Study in New Zealand
CompanyDrug

Epigenic Therapeutics Receives Approval for EPI-003 Clinical Study in New Zealand

Betta Pharmaceuticals' MCLA-129 Approved for Clinical Trial in Advanced Solid Tumors
CompanyDrug

Betta Pharmaceuticals’ MCLA-129 Approved for Clinical Trial in Advanced Solid Tumors

Xeltis AG Enrolls First Patient in US Pivotal Trial for aXess with FDA BTD Status
CompanyMedical Device

Xeltis AG Enrolls First Patient in US Pivotal Trial for aXess with FDA BTD Status

Huadong Medicine's DR10624 Receives NMPA Approval for MAFLD and MASH Clinical Trials
CompanyDrug

Huadong Medicine’s DR10624 Receives NMPA Approval for MAFLD and MASH Clinical Trials

Show More